ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2021. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,518,000 | +655.2% | 125,953 | +1655.4% | 0.01% | +500.0% |
| Q1 2021 | $201,000 | -80.2% | 7,175 | -63.7% | 0.00% | -85.7% |
| Q2 2020 | $1,015,000 | -28.3% | 19,763 | -16.8% | 0.01% | 0.0% |
| Q4 2019 | $1,416,000 | +331.7% | 23,750 | +190.3% | 0.01% | +600.0% |
| Q1 2019 | $328,000 | +63.2% | 8,182 | -44.0% | 0.00% | -75.0% |
| Q4 2013 | $201,000 | -31.2% | 14,615 | -5.7% | 0.00% | -55.6% |
| Q3 2013 | $292,000 | – | 15,506 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,818,835 | $59,618,000 | 21.09% |
| Bellevue Group AG | 4,519,164 | $95,580,000 | 0.93% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,713,176 | $36,234,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 572,267 | $12,103,000 | 0.82% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 64,434 | $1,363,000 | 0.45% |
| Boxer Capital, LLC | 500,000 | $10,575,000 | 0.37% |
| EMC Capital Management | 27,566 | $583,000 | 0.33% |
| WASATCH ADVISORS LP | 3,766,935 | $79,671,000 | 0.32% |
| Avidity Partners Management LP | 400,000 | $8,460,000 | 0.23% |
| Cinctive Capital Management LP | 186,170 | $3,937,000 | 0.18% |